The hospital “will not perform clitoroplasty or vaginoplasty in patients who are too young to participate in a meaningful discussion of the implications of these surgeries, unless anatomical differences threaten the physical health of the child,” a hospital spokesperson told The 19th.
Boston Children’s decision could reflect a turning point, activists said. It comes on the heels of a similar move by Chicago-based Ann and Robert H. Lurie Children’s Hospital, which said in July it would be ending cosmetic surgies on intersex infants.
“Now that there are two hospitals, people in the community are going to feel more ability to pressure their hospitals to do the same,” said Pidgeon Pagonis, co-founder of the Intersex Justice Project.
More articles on patient safety:
Insurance type may affect quality of surgical care, study finds
Arthritis drug may help severely ill COVID-19 patients if given early, study finds
Acute kidney injury boosts death risk in COVID-19 patients, Northwell study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
